← Open Payments lookup

KATHERINE ZUNIGA: Open Payments

NPI 1982272464 · MARSHALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,140 in 53 payments from 14 companies in 2025. Trend: 2023 $1,269 · 2024 $977 · 2025 $1,140

Food & beverage: $965Consulting: $175
CompanyPaymentsAmount
Amgen Inc.7$258
Bayer Healthcare Pharmaceuticals Inc.12$227
ABBVIE INC.7$183
AstraZeneca Pharmaceuticals LP6$106
Novo Nordisk Inc5$75
Lilly USA, LLC4$67
Sumitomo Pharma America, Inc.3$48
PENTAX of America, Inc.1$38
Exact Sciences Corporation2$34
Otsuka America Pharmaceutical, Inc.2$30

Products named: Kerendia, PROLIA, VRAYLAR, FARXIGA, OTEZLA, REXULTI, JARDIANCE, GEMTESA.

Industry payments across TX — which companies pay providers there.